Can Amygdala-Derived-EEG-fMRI-Pattern (EFP) Neurofeedback Treat Sleep Disturbances in PTSD?

Area of Science:

• Neuroscience
• Psychiatry
• Sleep Medicine

Background:

• Sleep disturbances are a primary symptom of post-traumatic stress disorder (PTSD), impacting up to 90% of patients.
• Existing PTSD treatments often fall short in resolving persistent sleep issues.
• Targeting the amygdala with neuromodulation presents a potential novel therapeutic avenue for PTSD-related sleep problems.

Purpose of the Study:

• To evaluate the efficacy of amygdala-derived EEG-fMRI-Pattern neurofeedback (Amyg-EFP-NF) in treating sleep disturbances associated with PTSD.
• To explore the temporal patterns of sleep improvement and their correlation with overall PTSD symptom reduction.
• To investigate potential associations between sleep improvement and cognitive reappraisal capacity.

Main Methods:

• A secondary analysis was conducted on a prospective, single-arm trial involving 58 participants with PTSD.
• Participants underwent 15 sessions of Amyg-EFP-NF over 8 weeks.
• Sleep outcomes were assessed using standardized measures (CAPS-5, PCL-5, PHQ-9 sleep items) at baseline, post-treatment, and 3-month follow-up.

Main Results:

• At 3-month follow-up, 63.79% of participants showed clinically significant reductions in sleep disturbances.
• Sleep improvement moderately correlated with overall PTSD symptom reduction (r = 0.484, p < 0.001).
• Sleep responders exhibited sustained improvement and significant increases in cognitive reappraisal, unlike non-responders.

Conclusions:

• Amyg-EFP-NF demonstrates preliminary promise as a treatment for PTSD-related sleep disturbances.
• Exploratory findings suggest distinct temporal patterns of sleep improvement and a link to enhanced cognitive reappraisal.
• Further investigation in randomized controlled trials is warranted to confirm these findings.